Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B

Hepatology

Volumn 29, Issue 2, 1999, Pages 572-575

  Ruiz Moreno, Mercedes ^a   Otero, Manuela ^a   Millán, Antonio ^a   Castillo, Inmaculada ^a   Cabrerizo, Maria ^a   Javier Jimenez E ^b   Oliva, Horacio ^a   Ramón y Cajal, Santiago ^c   Carreño, Vicente ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Clínica Puerta de Hierro ^*  (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; CYTOLYSIS; DNA DETERMINATION; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; BIOPSY; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; POLYMERASE CHAIN REACTION;

EID: 0033027489     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290230     Document Type: Article

References (24)

1. Su I-J, Iai M-Y, Hsu H-C, Chen D-S, Yang P-M, Chuang S-, Sung J-L. Diverse virological, histopathological and prognostic implications of seroconversion for hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. J Hepatol 1986;3:182-189.
2. Fattovich G, Rugge M, Brollo L, Pontisso P, Noventa F, Guido M, Alberti A, et al. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. HEPATOLOGY 1986;6:167-172.
3. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-634.
4. Carreno V, Castillo I, Molina J, Porres JC, Bartolomé J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992;15:102-106.
5. Lok ASF, Chung HT, Liu VW, Ma CCK. Long-term follow-up of chronic hepatitis B patients treated with Interferon alfa. Gastroenterology 1993;105:1833-1838.
6. Fong T-L, Di Bisceglie AM, Gerber A, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. HEPATOLOGY 1993;18:1313-1318.
7. Berninger M, Hammer M, Hoyer B, Gerin JL. An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol 1982;9:57-68.
8. López-Alcorocho JM, Moraleda G, Bartolome J, Castillo I, Cotonat T, Aguilar J, Ortega E, et al. Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers. J Hepatol 1994;21:353-360.
9. Castillo I, Bartolomé J, Navas S, González S, Herrero M, Carreno V Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon. HEPATOLOGY 1994;19:1331-1336.
10. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.
11. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. HEPATOLOGY 1987;7:758-763.
12. Hoofnagle JH, Peters G, Mullen KD, Jones DB, Rustgi V, Di Bisceglie AM, Hallahan C, et al. Randomized controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988;95:1318-1325.
13. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, et al. A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Mcd 1990;323:295-301.
14. Ruiz-Moreno M, Rúa MJ, Molina J, Moraleda G, Moreno A, García-Aguado J, Carreno V. Prospective, randomized controlled trial of interferon alpha in children with chronic hepatitis B. HEPATOLOGY 1991;13:1035-1039.
15. Lee P-I, Chang M-H, Lee C-Y, Hsu H-Y, Chen J-S, Chen P-J, Chen D-S. Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children. HEPATOLOGY 1990;12:657-660.
16. Hoofnagle JH, Dusheiko GM, Schafer DF, Jones A, Micetich KC, Young RC, Costa J. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982;96:447-449.
17. Lok ASF, Liang RHS, Chiu EKW, Wong K-L, Chan T-K, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991;100:182-108.
18. Payne RJH, Nowak MA, Blumberg BS. The dynamics of hepatitis B virus infection. Proc Natl Acad Sci U S A 1996;93:6542-6546.
19. Raimondo G, Schneider R, Stemler M, Smedile V, Rodino G, Will H. A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral replication and acute hepatitis. Virology 1990;179:64-68.
20. Perrillo RP, Brunt EM. Hepatic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen. Ann Intern Med 1991;115:113-115.
21. Chang M-H, Hsu H-Y, Hsu H-C, Ni Y-H, Chen J-S, Chen D-S. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: With special emphasis on the clearance of hepatitis B e antigen before 3 years of age. HEPATOLOGY 1995;22:1387-1392.
22. Marcellin P, Marlinot-Peignoux M, Loriot MA, Giostra E, Boyer N, Thiers V, Benhaou JP. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. Ann Intern Med 1990;112:227-230.
23. Molina J, Bartolomé J, Moraleda G, Ruiz-Moreno M, Ruáa MJ, Moreno A, Carreno Y Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver. J Med Virol 1992;38:11-15.
24. Paterlini P, Gerken G, Nakajima E, Terre S, D'Erico A, Giorgini W, Nalpas B, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary livers cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80-85.